Australian scientists developed a novel antiviral that targets the SARS-CoV-2 PLpro enzyme, showing strong preclinical ...

Severe Acute Respiratory Syndrome (SARS) is a disease that first appeared in humans in November 2002. Infection initially brings flu-like symptoms including fever and fatigue, but it then attacks ...

Otto and co-author Sean Edgerton, a PhD student focused on genomics and infectious diseases at the University of British ...

The risk for long COVID among pregnant individuals is lower than among matched nonpregnant women, according to study findings.

Key findings • Sarcoidosis patients are prone to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, increased severity, morbidity and greater mortality of coronavirus disease 2019 ...

No increased risk for new-onset T2D was found after mild SARS-CoV-2 infection in a multiethnic Asian cohort during the ...

By Dr. Liji Thomas, MD A study revealed that Jun13296, a novel PLpro inhibitor, demonstrates potent antiviral and ...

Several studies have reported that the coronavirus disease 2019 (COVID-19) can lead to heart rate variability (HRV), with the ...

The first mention of Covid-19 in the Queens Chronicle came on Jan. 30, 2020, in a story headlined “Coronavirus fears seep ...

VQ Biomedical, spun out of Duke University, has developed a novel, minimally invasive catheter designed to deliver oxygen directly to the bloodstream. The catheter bypasses the lungs, giving ARDS ...

VQ Biomedical, a startup born at Duke University, has secured $5 million in funding to advance a device it says will treat ...

SARS (severe acute respiratory syndrome) and MERS (Middle East respiratory syndrome) are serious infectious respiratory diseases that are caused by members of a class of viruses known as coronaviruses ...